tiprankstipranks
Trending News
More News >
Humana (CH:HUM)
:HUM

Humana (HUM) Price & Analysis

Compare
0 Followers

HUM Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.
---

Bulls Say, Bears Say

Bulls Say
Financial PerformanceHUM shares are up 4.2% benefiting from its largely domestic exposure and better than anticipated MA final rate notice.
Growth PotentialThe advance notice previewed an effective growth rate of +5.93%, the highest in the last 10 years, signaling strong growth potential.
Bears Say
Legal IssuesHUM's ongoing litigation with CMS on its MA Stars performance remains a key overhang on the stock.
Membership LossMedicare Advantage is expected to see -550k in membership losses in 2025, higher than originally expected.
---

Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.31%36.22%0.71%37.32%
36.22%
Mutual Funds
0.71% Other Institutional Investors
37.32% Public Companies and
Individual Investors

HUM FAQ

What was Humana’s price range in the past 12 months?
Currently, no data Available
What is Humana’s market cap?
Currently, no data Available
When is Humana’s upcoming earnings report date?
Humana’s upcoming earnings report date is Apr 30, 2025 which is 3 days ago.
    How were Humana’s earnings last quarter?
    Humana released its earnings results on Feb 11, 2025. The company reported -$1.78 earnings per share for the quarter, beating the consensus estimate of -$1.838 by $0.058.
      Is Humana overvalued?
      According to Wall Street analysts Humana’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does Humana pay dividends?
        Humana pays a Quarterly dividend of $0.732 which represents an annual dividend yield of 1.36%. See more information on Humana dividends here
          What is Humana’s EPS estimate?
          Humana’s EPS estimate is 8.22.
            How many shares outstanding does Humana have?
            Currently, no data Available
            What happened to Humana’s price movement after its last earnings report?
            Humana reported an EPS of -$1.78 in its last earnings report, beating expectations of -$1.838. Following the earnings report the stock price went same N/A.
              Which hedge fund is a major shareholder of Humana?
              Currently, no hedge funds are holding shares in CH:HUM
              ---

              Company Description

              Humana

              Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
              ---

              HUM Earnings Call

              Q4 2025
              0:00 / 0:00
              Earnings Call Sentiment|Neutral
              Humana's earnings call highlighted solid membership growth and operational efficiency improvements, alongside successful Medicaid expansion, indicating strong strategic positioning. However, challenges such as D SNP membership losses, Group Medicare Advantage margin pressures, Stars rating uncertainties, and elevated specialty drug costs underscore notable headwinds. The sentiment is balanced between positive strategic achievements and significant operational challenges.Read More>
              ---

              HUM Revenue Breakdown

              95.20%95.20%3.76%1.04%
              95.20% Premiums
              3.76% Services
              1.04% Investment income
              tipranks
              ---

              HUM Stock 12 Month Forecast

              Average Price Target

              $248.47
              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
              Similar Stocks
              Company
              Price & Change
              Follow
              Alnylam Pharma
              Centene
              Molina Healthcare
              Viatris
              Haleon PLC Sponsored ADR
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis